How Investors Will Assess You
In 2026, your systems matter as much as your sales.
In cannabis, everyone talks about market share. Sales volume. SKUs. Hype.
But as we enter 2026 with federal rescheduling on the horizon and 280E nearly behind us, investors are changing the questions they ask. They’re no longer just asking how much you sell, but rather:
- How well do you manage operations/risk?
- Can your systems scale consistently?
- What happens when a regulator shows up?
- Where are the liabilities hidden in your operations?
Welcome to the new valuation framework.
Compliance is not a cost center. It’s a valuation multiplier.
The Shift: From Revenue to Risk Control
In high-growth industries, valuation is often based on potential. But in cannabis, potential without process is a liability. Every other heavily regulated industry: pharmaceuticals, alcohol, tobacco, banking, healthcare, etc knows and operates on this principle.
With the barriers to capital finally breaking, especially as 280E fades and institutional capital eyes cannabis again, due diligence standards are rising fast.
The investors entering cannabis now aren’t cowboys. They’re family offices, funds, and traditional business strategics, and they come from industries where compliance is baked into valuation.
If your SOPs, CAPAs, audits, and internal controls aren’t ready?
Your risk profile will speak louder than your pitch deck.
The 5 Questions Every Cannabis Investor Should Be Asking in 2026
Whether you’re raising capital, positioning for merger/acquisition, or seeking distribution deals, here’s what savvy partners want to see:
-
Where are your SOPs, and when were they last updated?
Static documents from 2022 (or before) won’t cut it. Investors want to see living systems that match your actual operations and reflect current law. Ideally, with documentation to back up adherence. -
What does your audit trail look like?
Have you ever undergone a third-party compliance audit? What did it reveal? How did you respond? If your last “audit” was a surprise visit from the MED, you’re not in control; you’re reacting. -
Do you have a CAPA plan? Do you use it?
Can you demonstrate how you’ve handled past issues? Corrective and Preventive Action (CAPA) planning is standard in every mature industry. In cannabis, it’s still rare (even if required in some markets) and a major credibility differentiator. -
How is your team trained and tracked?
Investors want confidence that your employees aren’t just compliant on paper. Training logs, checklists, and periodic refreshers should be part of your internal culture, and not just your licensing binder. -
Are you HACCP-aligned?
For infused products, concentrates, flower, or edibles, HACCP (Hazard Analysis Critical Control Point) plans are becoming the expectation, especially as we align more closely with FDA models post-rescheduling. If you want to be prepared for interstate or international commerce one day, it’s vital you start practicing these standards now.
What This Means for Your Valuation
Compliance isn’t about avoiding fines anymore — it’s about justifying your future as a valuable business that’s survived this far.
Let’s look at two fictional companies, both doing $3M in annual revenue:
Company A
✘ No recent SOP updates
✘ No audit history
✘ Minimal training logs
✘ No HACCP or safety plans
✘ Reacts to issues
Company B
✔️ SOPs reviewed annually
✔️ Quarterly third-party audits with CAPAs
✔️ Documented onboarding & refresher tracking aligned with SOPs
✔️ HACCP-aligned SOPs with logs
✔️ Identifies issues proactively
It’s not about your top line. It’s about how well your systems protect the bottom line.
“We’ve Never Seen a 100% Compliant Facility.”
At iComply, we’ve audited hundreds of operators across the country. Not one has passed with 100% compliance.
That’s not an insult — it’s a reminder that compliance is a process, not a status.
The question isn’t whether you’ve ever been out of compliance or if you are “in compliance”. It’s whether you can prove you found it, fixed it, and documented the fix. And if you can prove you’ll continue to do so.
How iComply Helps You Build Your Value
- Monthly check-ins and issue tracking
- CAPA support and documentation systems implementation
- SOP reviews, reports, and updates
- Training schedules, certifications, and tracking
- HACCP-aligned support for Reduced Testing for facilities
- Investor-ready compliance documentation
“You never get more time. You get more team.” – Mark Slaugh, CEO, iComply
Start With an Audit
Not sure where you stand? Book a quick, no-risk High-Risk Audit for just $420. Or a more comprehensive one covering more than 400 compliance checkpoints.
In Cannabis, Everyone Has Problems. The Best Operators Manage Them Instead of Letting Problems Manage the Operation.
If you want your business to survive, scale, or sell in the next 24 months, you need systems that prove your business knows what it’s doing when no one is watching.
Let’s build them together with the oldest cannabis compliance company in the game.
📬 Request a Free initial consult.
📘 Learn more about our Compliance Review and Compliance Packages
📞 Talk to our team
